UBS Group’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.8M Buy
751,905
+301,758
+67% +$6.34M ﹤0.01% 2061
2025
Q1
$7.37M Buy
450,147
+31,662
+8% +$519K ﹤0.01% 2638
2024
Q4
$10.8M Buy
418,485
+278,938
+200% +$7.17M ﹤0.01% 2262
2024
Q3
$4.42M Sell
139,547
-89,258
-39% -$2.83M ﹤0.01% 2380
2024
Q2
$8.03M Sell
228,805
-14,244
-6% -$500K ﹤0.01% 1763
2024
Q1
$10.7M Buy
243,049
+92,347
+61% +$4.05M ﹤0.01% 1570
2023
Q4
$5.36M Buy
150,702
+94,167
+167% +$3.35M ﹤0.01% 1955
2023
Q3
$1.53M Buy
56,535
+47,486
+525% +$1.28M ﹤0.01% 2761
2023
Q2
$213K Sell
9,049
-47,405
-84% -$1.11M ﹤0.01% 4409
2023
Q1
$775K Sell
56,454
-58,149
-51% -$798K ﹤0.01% 3377
2022
Q4
$2.08M Buy
114,603
+99,753
+672% +$1.81M ﹤0.01% 2535
2022
Q3
$222K Buy
14,850
+10,244
+222% +$153K ﹤0.01% 3983
2022
Q2
$64K Sell
4,606
-71,765
-94% -$997K ﹤0.01% 4739
2022
Q1
$854K Sell
76,371
-40,996
-35% -$458K ﹤0.01% 3380
2021
Q4
$2.77M Buy
117,367
+72,996
+165% +$1.73M ﹤0.01% 2618
2021
Q3
$1.13M Buy
44,371
+21,160
+91% +$539K ﹤0.01% 3163
2021
Q2
$487K Buy
23,211
+10,846
+88% +$228K ﹤0.01% 3772
2021
Q1
$291K Buy
12,365
+11,506
+1,339% +$271K ﹤0.01% 4266
2020
Q4
$12K Buy
859
+601
+233% +$8.4K ﹤0.01% 6321
2020
Q3
$3K Sell
258
-3,557
-93% -$41.4K ﹤0.01% 6647
2020
Q2
$54K Buy
3,815
+3,113
+443% +$44.1K ﹤0.01% 4952
2020
Q1
$3K Buy
+702
New +$3K ﹤0.01% 6565
2019
Q4
Sell
-3,023
Closed -$27K 7092
2019
Q3
$27K Buy
+3,023
New +$27K ﹤0.01% 5587